News

Data from an automated refill reminder program identified key patient behaviors and characteristics that strongly predict medication nonadherence, which could enable more targeted interventions by health plans in the future.

From 2023 to 2024, the number of uninsured people in the United States rose for the first time since 2019, mainly because pandemic-era Medicaid protections ended, eligibility checks resumed and many people could not afford or access alternative coverage, according to a new issue brief from KFF.

The anti-obesity market is now the fourth largest and is expected to grow. The pipeline contains 190 obesity-related products, IQVIA’s Scott Biggs said.

How old a person appears may offer insight into how long they live after treatment for early-stage lung cancer.

In this interview, Luis Ortiz, M.D., explains how narcolepsy type 1 is now diagnosed and how it differs from type 2.

Navitus Health Solutions saw both overall savings and reduced patient costs from the switch to the adalimumab biosimilars. Vanderbilt Health, however, experienced increased adverse events after the biosimilar conversation and further switching to other biosimilars or therapies.

Evaluating the costs and outcomes of alternative funding programs requires balancing financial objectives with patient considerations.

A large study of more than 780,000 adolescents found that atopic dermatitis is not associated with lower academic performance on national exams in Denmark or England.

Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, explains where managed healthcare organizations should look if they want to improve PrEP access and align with public health goals.

In this video interview, Julie Kendle, Pharm.D., senior director of clinical pharmacy at IPD Analytics, provides an overview of the HIV preventative medicine landscape.

In this first part of a video interview series, Abby Kim, Pharm.D., of Prime Therapeutics shows how advances such as precision medicine and CAR T therapy are improving outcomes while requiring managed care leaders to rethink value through a long-term lens of cost, toxicity and patient access.

A talk by presidential historian Jon Meacham kicked off the official beginning of the meeting at the Music City Center in Nashville, Tennessee.

A multinational study found that metformin use was associated with significantly lower odds of esophageal squamous cell carcinoma, supporting further research into its potential role in cancer prevention and treatment.

A single-arm Japanese trial found that pazopanib did not improve progression-free survival but demonstrated encouraging response rates and overall survival in patients previously treated with paclitaxel.

A study in Translational Psychiatry found that adding rTMS to standard care may quickly improve flu-related sleep issues by targeting brain activity and immune responses linked to insomnia.

Adults in rural Appalachian Kentucky are facing a severe sleep crisis when compared to the rest of the country, a trend exacerbated by income inequality

The 2026 MHE Pharmacy Survey asked questions about most-favored nation drug pricing, PBM reform and HHS Secretary Robert F. Kennedy Jr.'s vaccine policies. Respondents rated direct-to-consumer drug sales by drugmaker as the most important development in the pharmaceutical sector this year.

New data from the Health Care Cost Institute shows that higher hospital prices and limited competition, not greater use of care, are the main reasons healthcare spending varies widely across U.S. metro areas.

Per- and polyfluoroalkyl substances seem to be associated with a high risk of reduced fertility, as well as maternal health concerns such as preeclampsia and gestational diabetes.

Lack of federal legislation and consolidation of hospitals into large health systems are among the reasons states are getting more involved in healthcare regulation and oversight.

The former chief health officer for Oracle sees artificial intelligence as the way to incorporate the many nonclinical factors that affect health into healthcare.

A convergence of legislative and judicial actions is creating PBM transparency, adding fiduciary responsibility, and addressing anti-competitive behavior, participants Jeffrey Hogan and Chad Worz, Pharm.D., said during a webinar sponsored by Managed Healthcare Executive and Drug Topics.

A new study found a specific brain and spinal cord circuit that appears to cause chronic pain after injury and could one day be targeted to treat pain without affecting the body's normal protective pain responses.

The pill version of Wegovy was available in January after the FDA approved it in December 2025. Eli Lillyʼs competitor, Foundayo (orforglipron) was approved by the FDA on April 1.

Nearly all U.S. adolescents who are at risk for HIV are missing out on preexposure prophylaxis, with significant disparities in access based on age, gender and geographic location.

Additionally, Orlando Health — Health Central Hospital is building a new cardiac catheterization laboratory with specialized electrophysiology equipment.